Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
DNA Repair (Amst). 2024 Sep;141:103739. doi: 10.1016/j.dnarep.2024.103739. Epub 2024 Jul 30.
Genomic interstrand crosslinks (ICLs) are formed by reactive species generated during normal cellular metabolism, produced by the microbiome, and employed in cancer chemotherapy. While there are multiple options for replication dependent and independent ICL repair, the crucial step for each is unhooking one DNA strand from the other. Much of our insight into mechanisms of unhooking comes from powerful model systems based on plasmids with defined ICLs introduced into cells or cell free extracts. Here we describe the properties of exogenous and endogenous ICL forming compounds and provide an historical perspective on early work on ICL repair. We discuss the modes of unhooking elucidated in the model systems, the concordance or lack thereof in drug resistant tumors, and the evolving view of DNA adducts, including ICLs, formed by metabolic aldehydes.
基因组链间交联 (ICLs) 是由正常细胞代谢过程中产生的反应性物质、微生物组产生的物质以及用于癌症化疗的物质形成的。虽然有多种依赖复制和不依赖复制的 ICL 修复选择,但每种修复的关键步骤都是将一条 DNA 链从另一条 DNA 链上解开。我们对解连环机制的大部分了解来自于基于质粒的强大模型系统,这些质粒将具有定义的 ICL 引入细胞或无细胞提取物中。在这里,我们描述了外源和内源性 ICL 形成化合物的特性,并提供了 ICL 修复早期工作的历史视角。我们讨论了在模型系统中阐明的解连环模式、耐药肿瘤中缺乏或缺乏的一致性,以及对代谢醛形成的 DNA 加合物(包括 ICL)的不断发展的看法。